OncLive - Clinical Oncology News, Cancer Expert Insights
OncLive - Clinical Oncology News, Cancer Expert Insights
Spotlight
OncClub: Join the Chat on Trending Trials in CancerComplimentary print subscription for home or office deliveryIn-person and virtual events just for HCPsLively expert panel discussions featuring peer-to-peer exchangesSubscribe to our eNewsletter for breaking news and curated content
Specialty
View MoreBreast CancerCAR T-cell TherapyChronic Lymphocytic LeukemiaGastrointestinal CancerGenitourinary CancersGynecologic OncologyImmuno-OncologyLung CancerMelanoma & Skin CancerMultiple MyelomaUrothelial Cancer
News
OncClub
All Oncology News
Pipeline Report
Rare Cancer Series
Media
Insights
Medical World News
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Thoracic Night Live
Conferences
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Partners
Publications
Oncology Live
Oncology Fellows
Supplements And Featured Publications
All Publications
CME/CE
Resources
Interactive Tools
Learning Modules
Presentations
Sponsored
Subscribe
eNewsletter
Print Subscription
  • Advertise
  • About OncLive
  • Editorial Board
  • CancerNetwork.com
  • CGTlive.com
  • CureToday.com
  • OncNursingNews.com
  • TargetedOnc.com
  • Contact Us
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information

© 2022 MJH Life Sciences and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.

Spotlight
  • OncClub: Join the Chat on Trending Trials in Cancer
  • Complimentary print subscription for home or office delivery
  • In-person and virtual events just for HCPs
  • Lively expert panel discussions featuring peer-to-peer exchanges
  • Subscribe to our eNewsletter for breaking news and curated content
SpecialtySee All >
  • Breast Cancer
  • CAR T-cell Therapy
  • Chronic Lymphocytic Leukemia
  • Gastrointestinal Cancer
  • Genitourinary Cancers
  • Gynecologic Oncology
  • Immuno-Oncology
  • Lung Cancer
  • Melanoma & Skin Cancer
  • Multiple Myeloma
  • Urothelial Cancer
OncLive SOSS
  • Advertise
  • About OncLive
  • Editorial Board
  • CancerNetwork.com
  • CGTlive.com
  • CureToday.com
  • OncNursingNews.com
  • TargetedOnc.com
  • Contact Us
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
  • MJHLS Brand Logo

2 Clarke Drive
Suite 100
Cranbury, NJ 08512

© 2022 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.

The Evolving Treatment Landscape in Relapsed/Refractory Diffuse Large B-Cell Lymphoma

EP. 1: DLBCL: Circumstances for Deviating Away From R-CHOP

January 29th 2021

EP. 2: DLBCL: Treatment Considerations for Challenging Populations

January 29th 2021

EP. 3: DLBCL: Treating Patients Following Relapse on Frontline Therapy

February 5th 2021

EP. 4: R/R DLBCL: Second-Line Treatment Options

February 5th 2021

EP. 5: Tafasitamab Combined With Lenalidomide in R/R DLBCL

February 12th 2021

EP. 6: R/R DLBCL: Treating With Tafasitamab-Lenalidomide

February 12th 2021

EP. 7: Novel Therapies for R/R DLBCL

February 19th 2021

EP. 8: CAR T-Cell Therapy for R/R DLBCL

February 19th 2021

EP. 9: CAR-T Treatment Options for R/R DLBCL

February 26th 2021

EP. 10: Treating R/R DLBCL With CAR-T: Current Barriers

February 26th 2021

EP. 11: Understanding the CAR-T Process: Collection Through Infusion

March 5th 2021

EP. 12: CAR T for R/R DLBCL: Safety/Tolerability

March 5th 2021

EP. 13: CAR T for R/R DLBCL: Improving Access and Utilization

March 12th 2021

EP. 14: R/R DLBCL: Transplants in the Era of CAR-T

March 12th 2021

EP. 15: Bridging Therapy in R/R DLBCL

March 19th 2021

EP. 16: Treating Primary Refractory DLBCL

March 19th 2021

EP. 17: R/R DLBCL: Novel Therapies in the Pipeline

March 26th 2021

EP. 18: R/R DLBCL: A Glance at Using Novel Therapies Moving Forward

March 26th 2021

EP. 19: Evolving Therapies in R/R DLBCL: Concluding Remarks

March 26th 2021